Uk Dri Ltd (uk Dementia Research Institute)

Quick Stats

• Annual Giving: £43.3 million (2023-24 expenditure)
• Total Assets: Significant (£290 million total committed funding for 2023-2028)
• Grant Range: £100,000 - £500,000 (for external applicants)
• Geographic Focus: England, Wales, and Scotland
• Primary Focus: Neurodegenerative disease and dementia research
• Funding Model: Primarily internal to 7 designated centres, with limited external opportunities

Contact Details

General Enquiries:

• Email: enquiries@ukdri.ac.uk
• Phone: +44 (0) 203 108 6538
• Website: https://ukdri.ac.uk/

Address:

Unit 3A, 3rd Floor

338 Euston Road

London, NW1 3BT

Press Enquiries:

• Email: press@ukdri.ac.uk
• Phone: +44 (0) 785 762 8080

Science Review Manager (Internal Awards):

Dr Aoife Kiely oversees internal award programmes for UK DRI members

Overview

UK DRI Ltd, established in 2017, is the UK Dementia Research Institute - the single largest investment in dementia research in the UK to date. The organization was founded through a £250 million partnership between the Medical Research Council (MRC), Alzheimer's Society, and Alzheimer's Research UK. In 2024, the institute secured renewed funding of £150 million for 2023-2028, plus an additional £20 million commitment from the National Institute for Health and Care Research (NIHR).

The institute operates primarily as a funding body for seven designated research centres located at University College London (the Hub), University of Cambridge, Cardiff University, University of Edinburgh, Imperial College London (two centres), King's College London, and University of Surrey. With over 800 researchers across these centres, UK DRI has established itself as a world leader in discovery science in neurodegeneration and is one of the most cited institutes in the field.

Under the leadership of Director Professor Siddharthan Chandran (appointed October 2023), UK DRI's mission is to predict dementia risk before symptoms appear, prevent the onset of neurodegenerative conditions, and personalize care and treatment for every individual affected by dementia. The institute's 2024 governance review earned an “excellent” rating from the MRC.

Funding Priorities

Grant Programs

For External Researchers:

• Partnership with Dementia Discovery Fund
• Open to UK DRI centres AND other academic UK-based research groups
• Focus on therapeutic targets and therapeutics
• Covers all forms of dementia
• Includes funding, mentoring, business development and project guidance
• Rolling application process (specific deadlines announced periodically)

• Open to early career researchers (maximum 6 years postdoctoral experience)
• Particularly encourages applicants from outside neuroscience or with industry experience
• Focus on AI/machine learning applications in dementia research
• Application deadline: December 4th (for 2025 round), with interviews/outcomes in March 2026
• Opens September 24, 2025

For UK DRI Centre Members Only:

• Pilot Awards: For postdocs in UK DRI Group Leaders' labs
• Cross-Centre Collaboration Awards: £220,000 for 3 years (pairs of Group Leaders from different centres)
• Translational Awards: Support for innovative translation projects
• Inter-UK DRI Travel Bursaries: For early career researchers

Priority Areas

UK DRI organizes research around seven thematic networks:

1. Motor Neuron Disease (MND/ALS): Pathways to degeneration, biomarkers, therapeutic targets
2. Glia: Role of astrocytes, microglia, and oligodendrocytes in neurodegeneration
3. Neuroimmune Interactions: Chronic immune activation in neurodegenerative diseases
4. Vascular: Vascular contributions to dementia (second most common cause)
5. Synapse: Mechanisms of synapse damage and vulnerability
6. Parkinson's Disease: Molecular biology to translational studies, digital and blood biomarkers
7. Cellular Processes of Ageing: DNA repair and protein aggregation

Strategic priorities include:

• Developing AI and machine learning approaches
• Translation of discoveries into therapeutics, diagnostics, and technologies
• Clinical trials acceleration (including £20m Dementia Trials Accelerator with Health Data Research UK)
• Industry partnerships and commercialization
• International collaboration (e.g., UK-India healthy brain ageing initiative)

What They Don't Fund

• Research outside neurodegenerative disease and dementia
• Individual researchers not affiliated with UK institutions (for most programs)
• Projects without clear relevance to dementia or related neurodegenerative conditions
• Applicants beyond early career stage for the fellowship program (>6 years post-PhD)

Ready to write a winning application for Uk Dri Ltd (uk Dementia Research Institute)?

Our AI helps you craft proposals that match their exact priorities. Save hours and increase your success rate.

Learn more >

Governance and Leadership

Director:

Professor Siddharthan Chandran (from October 2023) - A practising neurologist and world-leading expert in neurodegenerative diseases, renowned for work in motor neuron disease (MND) and MS combining laboratory and clinical research with focus on human/patient stem cells. He leads with support from the Board of Trustees, Scientific Directors, and Operational Leadership Team.

Chair of Board of Trustees:

William Rucker - CEO of Lazard in the UK, joined UK DRI Board in November 2017. Previously Chairman of Quintain (property developer) and co-founder of Newbridge (eating disorder business). Also Chairman at Intermediate Capital Group Plc and The British Land Co. Plc.

Recent Trustee Appointments (2023):

• Emma Whitcombe (Charity Consultant)
• Rabia Khan (Serna Bio)
• Roudie Shafie (OVID Health)

Board Structure:

The Board of Trustees meets in person four times per year, incorporating centre visits. They have collective responsibility for governance, annual budget approval, strategic direction, and major policies.

Key Strategic Quote from Director Chandran:

“I am delighted to have the opportunity to lead the UK DRI whose ultimate aim is to transform the outlook for people at risk of or living with dementia and related neurodegenerative conditions.”

How to Apply to Uk Dri Ltd (uk Dementia Research Institute)

How to Apply

For D3A (Dementia Drug Discovery Accelerator):

• Applications accepted from UK DRI centres and other academic UK-based research groups
• Visit UK DRI website for current call announcements
• Contact enquiries@ukdri.ac.uk for guidance
• Applications include funding, plus mentoring and business development support

For Race Against Dementia AI Innovation Fellowship:

• Applications open September 24, 2025
• Deadline: December 4, 2025 at 4pm GMT
• Application portal available through UK DRI website
• Applicants currently external to UK DRI need to contact the Awards team to generate an account
• Focus on AI approaches to advance understanding of dementia

For Industry/Academic Partnerships:

• Contact UK DRI's Business & Innovation and Science teams
• Bespoke partnerships tailored to research needs
• Single contractual framework across all UK DRI centres streamlines commercialization

Decision Timeline

Race Against Dementia Fellowship:

• Applications due: December 4, 2025
• Interviews and outcomes: March 2026

D3A:

• Timeline varies by call
• Typically includes mentoring and business development support during and after decision

General:

UK DRI's collaborative approach means decision timelines can be flexible for partnership discussions.

Success Rates

Specific success rates not publicly available. However:

• UK DRI funded 4 Translation Awards, 10 Pilot Projects (second round), and multiple Cross-Centre Awards in recent rounds
• First D3A round anticipated funding “multiple applications”
• Over 800 researchers currently working within UK DRI network
• Institute has launched 4 spin-out companies since establishment

Reapplication Policy

Not explicitly stated in public materials. For fellowship programs managed through external partners (like Race Against Dementia via Alzheimer's Research UK), their reapplication policies would apply.

Application Success Factors

For D3A Applications:

• Focus on therapeutic targets and therapeutics
• Demonstrate clear translation potential from research to clinic
• Show innovation and entrepreneurial thinking
• Emphasize all forms of dementia (not limited to Alzheimer's)
• Highlight how project benefits from business development and mentoring support
• UK-based academic research groups eligible

For Race Against Dementia AI Innovation Fellowship:

• Maximum 6 years postdoctoral experience (career stage is critical)
• Strong AI/machine learning methodology component
• Applications from outside traditional neuroscience field particularly welcome
• Industry experience viewed positively
• Industrial partner involvement welcomed (as collaborator, financial or in-kind contribution)
• Clear dementia relevance (mechanisms, risk factors, markers, diagnosis, patient impact)
• Strategic alignment with advancing AI approaches in dementia research

For Partnership Opportunities:

• Access to UK DRI's nearly 1,000 neurodegeneration experts
• UK DRI's uniquely competitive IP structure and single contractual framework valued by industry
• Open, collaborative operating model
• Focus on translation and innovation
• Track record: 5 major strategic partnerships with industry since establishment (including £30m partnership with LifeArc)

General Success Factors:

• Alignment with UK DRI's thematic networks (MND, Glia, Neuroimmune, Vascular, Synapse, Parkinson's, Cellular Ageing)
• Innovation in methodology or approach
• Translation potential for diagnostics, therapeutics, or technologies
• Collaborative approach across disciplines or institutions
• Evidence of rigorous science with clinical relevance

Key Takeaways for Grant Writers

• Limited External Access: UK DRI primarily funds its 7 designated centres. External researchers have access mainly through D3A and the Race Against Dementia fellowship - target these opportunities carefully.

• Translation is Key: UK DRI explicitly prioritizes translation of discoveries into therapeutics, diagnostics, and technologies. Projects should demonstrate clear pathway to clinical impact.

• AI Priority: The Race Against Dementia fellowship strongly prioritizes AI and machine learning approaches - this is a strategic priority for the institute.

• Non-Traditional Backgrounds Welcome: For the fellowship, applicants from outside neuroscience or with industry experience are particularly encouraged - this is explicitly stated.

• Early Career Focus for Fellowships: Maximum 6 years post-PhD for the Race Against Dementia fellowship is a hard eligibility criterion.

• Partnership Culture: UK DRI's collaborative, open operating model and streamlined IP framework make them accessible for industry and academic partnerships beyond traditional grant applications.

• Broader Than Alzheimer's: UK DRI covers all forms of dementia and neurodegenerative conditions, including MND, Parkinson's, vascular dementia, and FTD - not just Alzheimer's disease.

Similar Funders

These funders have a similar focus and geographic reach:

• Alzheimer's Research Uk
• Race Against Dementia
• The Lewy Body Society
• Dementia Research Uk
• The Galen And Hilary Weston Foundation
• Brain Research Uk
• The Kennedy Trust For Rheumatology Research
• The Cure Parkinson's Trust
• Retina Uk
• Brace

References

1. UK DRI Official Website - https://ukdri.ac.uk/
2. UK DRI Board of Trustees - https://www.ukdri.ac.uk/board-of-trustees
3. Charity Commission Register - UK DRI Ltd, Charity Number 1179589
4. “Professor Siddharthan Chandran appointed as new Director of the UK DRI” - https://www.ukdri.ac.uk/news-and-events/professor-siddharthan-chandran-appointed-as-new-director-of-the-uk-dri
5. “£131m renewed funding and new director for dementia institute” - UKRI, https://www.ukri.org/news/131m-renewed-funding-and-new-director-for-dementia-institute/
6. “D3A: Launching our new research accelerator partnership with DDF” - https://www.ukdri.ac.uk/news-and-events/d3a
7. “UK DRI and Race Against Dementia AI Innovation Fellowship Scheme” - https://www.raceagainstdementia.com/research/ukdri
8. "Race Against Dementia Fellowships 2025 – Info + Q&A" - DEMENTIA RESEARCHER, https://www.dementiaresearcher.nihr.ac.uk/race-against-dementia-fellowships-2025-info-qa/
9. “Funding opportunities with our new Science Review Manager, Aoife Kiely” - https://www.ukdri.ac.uk/news-and-events/funding-opportunities-with-our-new-science-review-manager-aoife-kiely
10. “Why partner with the UK DRI?” - https://www.ukdri.ac.uk/news-and-events/why-partner-uk-dri
11. “UK DRI Research Themes” - https://ukdri.ac.uk/research-themes
12. “Major funding sets UK DRI on track for next phase of dementia discovery research” - https://www.ukdri.ac.uk/news-and-events/major-funding-sets-uk-dri-on-track-for-next-phase-of-dementia-discovery-research
13. “Welcoming our Chairman: William Rucker” - https://ukdri.ac.uk/news-and-events/welcoming-our-chairman-william-rucker